COMP <GO>
RVTY vs BRKR // DIVIDEND YIELD & FCF PAYOUT SAFETY
Revvity Inc. (NYSE) VS. Bruker Corporation (NASDAQ) • 15-METRIC TALLY: RVTY 10
— BRKR 3
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: BRKR
LAST: $151.60 (-3.44%) • MKT CAP: $17.52B
dividend-safety
0.18%
LAST: $55.69 (-2.42%) • MKT CAP: $8.70B
dividend-safety
0.24%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RVTY VS. BRKR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RVTY | BRKR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 45.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 1.30% | +1.80 | RVTY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 48.2x | 75.7x | -27.50 | RVTY | /valuation <GO> |
| Free Cash Flow Yield | 2.75% | 0.46% | +2.29 | RVTY | /fcf-yield <GO> |
| Operating Margin | 12.50% | 2.00% | +10.50 | RVTY | /operating-margins <GO> |
| Net Profit Margin | 8.40% | -0.20% | +8.60 | RVTY | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 2.10% | +1.60 | RVTY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.18% | 0.24% | -0.06 | BRKR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.37 | 2.81 | +0.56 | RVTY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | RVTY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.9 | 45.8 | +6.10 | RVTY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.97 | -0.02 | BRKR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 71.3x | 22.0x | +49.30 | BRKR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $17.52B | $8.70B | $8.82B | RVTY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RVTY REV | BRKR REV | RVTY GROSS % | BRKR GROSS % | RVTY FCF | BRKR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.86B | $3.44B | — | 45.9% | $509.4M | $43.3M |
| FY 2024 | $2.76B | $3.37B | — | 49.0% | $541.7M | $136.0M |
| FY 2023 | $2.75B | $2.96B | — | — | -$32.5M | $216.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RVTY // BETA 0.95
BRKR // BETA 0.97